| SC 13D/A | 2019-08-20 | BP Peptides, LLC | Capstone Therapeutics Corp. | 22,920,008 | 39.0% | EDGAR |
| SC 13D/A | 2019-03-19 | BP Peptides, LLC | Capstone Therapeutics Corp. | 21,946,348 | 38.0% | EDGAR |
| SC 13G/A | 2019-02-13 | SUBIN NEIL S | Capstone Therapeutics Corp. | 7,554,422 | 13.9% | EDGAR |
| SC 13G | 2019-02-11 | Alimco Financial Corp | Capstone Therapeutics Corp. | 103,000 | 0.2% | EDGAR |
| SC 13D/A | 2018-11-20 | BP Peptides, LLC | Capstone Therapeutics Corp. | 21,467,499 | 37.5% | EDGAR |
| SC 13D/A | 2018-05-18 | BP Peptides, LLC | Capstone Therapeutics Corp. | 20,488,518 | 36.4% | EDGAR |
| SC 13D/A | 2018-02-01 | BP Peptides, LLC | Capstone Therapeutics Corp. | 19,525,498 | 35.3% | EDGAR |
| SC 13G | 2018-01-23 | SUBIN NEIL S | Capstone Therapeutics Corp. | 7,657,422 | 14.1% | EDGAR |
| SC 13D | 2017-07-24 | BP Peptides, LLC | Capstone Therapeutics Corp. | 18,541,197 | 34.1% | EDGAR |
| SC 13G/A | 2017-07-18 | BIOTECHNOLOGY VALUE FUND L P | Capstone Therapeutics Corp. | 1,377,652 | 2.5% | EDGAR |
| SC 13G/A | 2017-01-26 | MILLER LLOYD I III | Capstone Therapeutics Corp. | 7,757,422 | 19.0% | EDGAR |
| SC 13G | 2016-03-24 | MILLER LLOYD I III | Capstone Therapeutics Corp. | 7,926,389 | 19.4% | EDGAR |
| SC 13G/A | 2016-02-16 | BIOTECHNOLOGY VALUE FUND L P | Capstone Therapeutics Corp. | 1,619,888 | 4.0% | EDGAR |
| SC 13G/A | 2015-02-17 | BIOTECHNOLOGY VALUE FUND L P | Capstone Therapeutics Corp. | 1,619,888 | 4.0% | EDGAR |
| SC 13D | 2014-05-08 | MILLER LLOYD I III | Capstone Therapeutics Corp. | 7,926,389 | 19.4% | EDGAR |
| SC 13G/A | 2014-02-12 | MILLER LLOYD I III | Capstone Therapeutics Corp. | 7,926,389 | 19.4% | EDGAR |
| SC 13G/A | 2013-02-12 | MILLER LLOYD I III | Capstone Therapeutics Corp. | 6,399,889 | 15.7% | EDGAR |
| SC 13G | 2012-11-29 | MILLER LLOYD I III | Capstone Therapeutics Corp. | 6,107,889 | 14.9% | EDGAR |
| SC 13G/A | 2011-09-09 | BIOTECHNOLOGY VALUE FUND L P | Capstone Therapeutics Corp. | 1,619,888 | 4.0% | EDGAR |
| SC 13G/A | 2011-02-11 | RENAISSANCE TECHNOLOGIES LLC | Capstone Therapeutics Corp. | 2,011,300 | 4.9% | EDGAR |